NO985341L - Formulering omfattende mikropartikler for inhalering - Google Patents

Formulering omfattende mikropartikler for inhalering

Info

Publication number
NO985341L
NO985341L NO985341A NO985341A NO985341L NO 985341 L NO985341 L NO 985341L NO 985341 A NO985341 A NO 985341A NO 985341 A NO985341 A NO 985341A NO 985341 L NO985341 L NO 985341L
Authority
NO
Norway
Prior art keywords
microparticles
inhalation
formulation
hfc
homogeneously
Prior art date
Application number
NO985341A
Other languages
English (en)
Other versions
NO985341D0 (no
Inventor
Ian Joseph Smith
Cheryl Vanessa Rogerson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO985341D0 publication Critical patent/NO985341D0/no
Publication of NO985341L publication Critical patent/NO985341L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mikropartikler med en størrelse opp til 50 pm omfattende et terapeutisk middel og en surfaktant. De kan formuleres homogent med et HFC-drivstoff.
NO985341A 1996-05-17 1998-11-16 Formulering omfattende mikropartikler for inhalering NO985341L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation
PCT/GB1997/001309 WO1997044012A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation

Publications (2)

Publication Number Publication Date
NO985341D0 NO985341D0 (no) 1998-11-16
NO985341L true NO985341L (no) 1998-11-16

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985341A NO985341L (no) 1996-05-17 1998-11-16 Formulering omfattende mikropartikler for inhalering

Country Status (9)

Country Link
JP (1) JP2000512268A (no)
KR (1) KR20000011020A (no)
AR (1) AR007178A1 (no)
AU (1) AU2783897A (no)
CA (1) CA2253478A1 (no)
GB (1) GB9610341D0 (no)
NO (1) NO985341L (no)
WO (1) WO1997044012A1 (no)
ZA (1) ZA974328B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
PT1107743E (pt) * 1998-08-25 2007-10-01 Advanced Inhalation Res Inc Formulações proteicas estáveis secas por pulverização
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
RU2147226C1 (ru) * 1994-09-29 2000-04-10 Квадрант Хэлткэа (Ю Кей) Лимитед Высушенные распылением микрочастицы как терапевтические носители

Also Published As

Publication number Publication date
NO985341D0 (no) 1998-11-16
KR20000011020A (ko) 2000-02-25
WO1997044012A1 (en) 1997-11-27
CA2253478A1 (en) 1997-11-27
ZA974328B (en) 1998-05-19
AU2783897A (en) 1997-12-09
AR007178A1 (es) 1999-10-13
GB9610341D0 (en) 1996-07-24
JP2000512268A (ja) 2000-09-19

Similar Documents

Publication Publication Date Title
NO985341L (no) Formulering omfattende mikropartikler for inhalering
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
IL131626A0 (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof
ATE269054T1 (de) Konfekt zusammensetzungen
AU3490300A (en) Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
ES2153908T3 (es) Composiciones para revestimiento con propiedades antirreflectoras y antiempañamiento.
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
BR9916973A (pt) Tablete detergente de composição particulada compactada, processo para produzir o mesmo, tablete que tem um par de faces opostas afastadas uma da outra e unidas por uma superfìcie periférica do tablete, e, processo para produzir o mesmo
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
IL160109A0 (en) Topical pharmaceutical formulation
MY100759A (en) Shampoo composition
EP0671658B8 (en) Exposure apparatus and reflection type mask to be used in the same
NZ239879A (en) Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
FI925284L (fi) Inkapslade partiklar anvaendbara som kontrastmedel i kompositioner och metoder, som anvaends vid ultraljud- och roentgenavbildning
AU2001290649A1 (en) Method and apparatus for increasing the efficiency of transactions and connection sharing in an enterprise environment
ZA971892B (en) Compositions and use of benzamides and nicotin-amides as anti-inflammatory agents
PL362965A1 (en) Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
DE69526350D1 (de) Abschuppungs-zusammensetzung
WO2002051535A3 (en) Preparation of microparticles having improved flowability
DE69714847D1 (de) Instant vesikuläres produkt
DK0841933T3 (da) Præparater med Bowman-Birk-inhibitor til behandling af inflammatoriske sygdomme